336 related articles for article (PubMed ID: 3578330)
1. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
Chin NX; Neu HC
Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
[TBL] [Abstract][Full Text] [Related]
2. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria.
Berlanga M; Montero MT; Hernández-Borrell J; Viñas M
Int J Antimicrob Agents; 2004 Jun; 23(6):627-30. PubMed ID: 15194135
[TBL] [Abstract][Full Text] [Related]
3. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
Drabu YJ; Blakemore PH
Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
Moody JA; Gerding DN; Peterson LR
Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
[TBL] [Abstract][Full Text] [Related]
5. The post-antimicrobial suppressive effect of quinolone agents.
Neu HC; Kumada T; Chin NX; Mandell W
Drugs Exp Clin Res; 1987; 13(2):63-7. PubMed ID: 3107958
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
[TBL] [Abstract][Full Text] [Related]
7. Overview of Scandinavian in vitro studies with ciprofloxacin.
Forsgren A
Scand J Infect Dis Suppl; 1989; 60():16-22. PubMed ID: 2667106
[TBL] [Abstract][Full Text] [Related]
8. The postantibiotic effect.
Spivey JM
Clin Pharm; 1992 Oct; 11(10):865-75. PubMed ID: 1341993
[TBL] [Abstract][Full Text] [Related]
9. Post-antibiotic effect of three quinolones against gram negative isolates from urine.
Alados JC; Gutierrez J; Garcia F; Liebana J; Piedrola G
Med Lab Sci; 1990 Oct; 47(4):272-7. PubMed ID: 2283929
[TBL] [Abstract][Full Text] [Related]
10. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
[TBL] [Abstract][Full Text] [Related]
11. The postantibiotic effect induced by antimicrobial combinations.
Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial effect of NSAIDS on clinical isolates of urinary tract infection and diabetic foot infection.
Akhter T; Baqai R; Aziz M
Pak J Pharm Sci; 2010 Jan; 23(1):108-13. PubMed ID: 20067876
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
[TBL] [Abstract][Full Text] [Related]
15. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
[TBL] [Abstract][Full Text] [Related]
16. [Post-antibiotic effect of imipenem, amikacin and ciprofloxacin against various strains of Serratia marcescens].
Bollet C; Mallet MN; Bouchemal H; de Micco P
Pathol Biol (Paris); 1990 May; 38(5):446-9. PubMed ID: 2195454
[TBL] [Abstract][Full Text] [Related]
17. The post-antibiotic effects of linezolid against Gram-positive pathogens.
Hosgor-Limoncu M; Ermertcan S; Tasli H; Aydemir S
Saudi Med J; 2007 Apr; 28(4):551-4. PubMed ID: 17457476
[TBL] [Abstract][Full Text] [Related]
18. [In vitro comparison of ciprofloxacin with other antibiotics against multiresistant gram-negative bacilli].
Soto Hernández JL; Angeles Morales V; Perea Mejía B; Hernández Velázquez M; Martínez Zubieta R; Pasquel Rivera C
Rev Invest Clin; 1991; 43(4):318-22. PubMed ID: 1798865
[TBL] [Abstract][Full Text] [Related]
19. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
20. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
Piccolomini R; Ravagnan G
Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]